Absorica Capsule
Product Images NDC 10631-118

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Absorica (NDC 10631-118). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Absorica 01)

Chemical structure diagram of the active ingredient for Absorica LD, showing a polyunsaturated carboxylic acid with a cyclohexene ring and a carboxyl group (COOH) at one end. The structure highlights multiple double bonds and methyl groups along the carbon chain.*

FDA Label Image

Figure 1 (Absorica 02)

Line chart comparing the mean lesion count over analysis visits from Baseline through Week 20 for Absorica and Isotretinoin. The chart shows lesion counts decreasing progressively over time for both medications, with data points marked at Baseline, Week 4, Week 8, Week 12, Week 16, and Week 20.*

FDA Label Image

Blister 10mg (Absorica 03)

Absorica LD packaging label detailing warnings, storage instructions, and patient information. The label emphasizes serious birth defect risks and special warnings for female patients, including a patient information consent form. It includes detailed instructions on usage and storage at controlled room temperature, manufactured and distributed by Sun Pharmaceutical Industries, Inc.*

FDA Label Image

Carton-10mg (Absorica 04)

Packaging label for Absorica LD 10 mg isotretinoin capsules by Sun Pharmaceutical Industries, Inc. The label states each capsule contains 10 mg isotretinoin, USP, with 30 capsules per container (3 x 10 prescription packs). The label includes warnings about pregnancy contraindication and instructions to pharmacists to dispense prescription packs intact.*

FDA Label Image

Blister 20mg (Absorica 05)

Absorica LD packaging label for the 20 mg soft gelatin capsules manufactured by Sun Pharmaceutical Industries, Inc. The orange and white carton includes warnings for female patients about serious birth defects and detailed storage instructions. The label also contains a barcode, manufacturer information, and a medication guide reminder. The packaging features multiple images of the capsule strip with specific use and handling instructions.*

FDA Label Image

Carton 20mg (Absorica 06)

Absorica 20 mg (isotretinoin) Capsules packaging label from Sun Pharmaceutical Industries, Inc. The carton contains 30 capsules in 10 prescription packs. The label emphasizes prescription dispensing, pregnancy contraindications, storage conditions (20°-25°C, protect from light), and a warning that Absorica and Absorica LD are not interchangeable due to bioavailability and dosage differences.*

FDA Label Image

Blister 25mg (Absorica 07)

This is a multi-panel drug facts and patient information sheet for Absorica LD, 25 mg capsules by Sun Pharmaceutical Industries, Inc. It includes important pregnancy warnings highlighting serious birth defects, instructions for female patients to avoid pregnancy, storage conditions, and detailed guidance on mental health risks such as depression and psychosis. Illustrations emphasize birth defect risks and proper use instructions.*

FDA Label Image

Carton 25mg (Absorica 08)

Packaging label for Absorica LD 25 mg isotretinoin capsules by Sun Pharmaceutical Industries, Inc. The label shows a 30-capsule count (3 x 10 prescription packs) with each capsule containing 25 mg isotretinoin. The front panel includes warnings about birth defects and guidance to dispense with a medication guide. Storage instructions and contraindications for pregnancy are also noted.*

FDA Label Image

Blister 30mg (Absorica 09)

Absorica LD 30 mg capsules packaging label by Sun Pharmaceutical Industries, Inc. The label includes warnings prominently stating the serious birth defects risk for female patients and instructions for safe use, emphasizing the requirement that female patients do not get pregnant. The label also contains storage instructions, patient safety information, and detailed usage instructions in black and red text on a white background.*

FDA Label Image

Carton 30mg (Absorica 10)

Absorica 30 mg (isotretinoin) Capsules packaging label by Sun Pharmaceutical Industries, Inc. This carton contains 30 capsules (3 x 10 prescription packs) with warnings about birth defects and pharmacist dispensing instructions. The label emphasizes prescription integrity, storage conditions, and differences between Absorica and Absorica LD.*

FDA Label Image

Blister 35mg (Absorica 11)

Absorica LD 35 mg soft gelatin capsules packaging label by Sun Pharmaceutical Industries, Inc. The label includes warnings that Absorica causes serious birth defects and is for female patients who must not get pregnant. It highlights severe birth defects associated with isotretinoin use and advises on proper storage conditions. The label also contains detailed safety information, usage warnings, and instructions to read patient information carefully.*

FDA Label Image

Carton 35mg (Absorica 12)

Packaging label for Absorica 35 mg isotretinoin capsules by Sun Pharmaceutical Industries, Inc. The label provides dosage strength of 35 mg, package size of 30 capsules (3 x 10 prescription packs), and warnings including contraindication in pregnancy and the requirement to protect the product from light. Additional notes emphasize that Absorica and Absorica LD are not bioequivalent and should not be interchanged.*

FDA Label Image

Blister 40mg (Absorica 13)

Packaging label for Absorica LD 40 mg softgel capsules by Sun Pharmaceutical Industries, Inc. The label features prominent warnings for female patients to not get pregnant due to serious birth defects. It includes detailed safety information, usage instructions, and a diagram of capsule placement. The design uses red and black text on a white background, with boxes and arrows to organize warnings and instructions clearly.*

FDA Label Image

Carton 40mg (Absorica 14)

Absorica 40 mg isotretinoin capsules packaging label by Sun Pharmaceutical Industries, Inc. The label highlights that each capsule contains 40 mg of isotretinoin, USP. The package contains 30 capsules divided into 3 prescription packs of 10 capsules each. Warnings include protection from light and caution against use during pregnancy due to birth defects risk.*

FDA Label Image

Absorica Ld-8mg-carton (Absorica 16)

Absorica LD 8 mg acetretin capsules packaging label, containing 30 capsules in 3 prescription packs of 10 each. The label includes dosage form and strength details, warnings about pregnancy risks and dispensing instructions, and manufacturer information for Sun Pharmaceutical Industries, Inc. The label also features storage instructions and reminder warnings for pharmacists regarding patient authorization and prescription limits.*

FDA Label Image

Absorica Ld-16mg-carton (Absorica 18)

Absorica LD 16 mg capsules, USP label showing a carton designed for 30 capsules (3x10 prescription packs). The label highlights isotretinoin as the active ingredient, with warnings about pregnancy and medication guides. Manufactured by Ohm Laboratories, distributed by Sun Pharmaceutical Industries, Inc., featuring drug information and safety instructions.*

FDA Label Image

Pdp-24 mg Carton (Absorica 20)

Absorica LD 24 mg capsules carton label from Sun Pharmaceutical Industries, Inc. Contains 30 capsules (3 x 10 prescription packs), each with 24 mg isotretinoin. The label includes warnings about contraindications in pregnancy and pharmacist dispensing instructions, along with storage conditions and manufacturer details. It emphasizes protecting the product from light and notes the medication guide enclosed.*

FDA Label Image

Pdp-32mg Carton (Absorica 22)

Absorica LD 32 mg (isotretinoin) Capsules USP packaging label featuring 30 capsules in 3 prescription packs. The label includes dosage strength, active ingredient name, warnings about pregnancy contraindication, handling instructions, and the manufacturer Sun Pharmaceutical Industries, Inc. The front label emphasizes pharmacist attention for dispensing with the medication guide.*

FDA Label Image

Spl Absorica Ld 16 mg Wallet

This image shows detailed text panels for Absorica LD, including dosage forms of 8 mg and 16 mg strength capsules. The panels feature important safety information, warnings for female patients, instructions on drug use, and directions for patients. Illustrations show proper capsule insertion and use. The labeler is Sun Pharmaceutical Industries, Inc.*

FDA Label Image

Spl Absorica Ld 24 mg Wallet

Absorica LD labeling includes patient warnings, special warnings for female patients, and drug usage precautions. The label shows various strengths of Absorica LD capsules with detailed instructions and safety information from Sun Pharmaceutical Industries, Inc. It includes blister pack diagrams and highlights the importance of avoiding pregnancy during treatment.*

FDA Label Image

Spl Absorica Ld 32 mg Wallet

Packaging label for Absorica LD capsules, featuring multiple strength options including 8 mg, 10 mg, 16 mg, 20 mg, 24 mg, 25 mg, 30 mg, 32 mg, 35 mg, and 40 mg. The label includes the proprietary name, active ingredient strength per capsule, dosing information, warnings specifically for female patients regarding pregnancy risks, and manufacturer details for Sun Pharmaceutical Industries, Inc. Tablets are shown in blister packs with a detailed visual layout of capsule placement and dosage tracking.*

FDA Label Image

Spl Absorica Ld Wallet 8 mg

This image shows a detailed patient information insert for Absorica LD, including dosage strength (8 mg), warnings specifically for female patients regarding pregnancy prevention, and precautions about possible risks like severe birth defects. It includes graphical elements such as diagrams and pill images related to medication administration and safety guidelines provided by Sun Pharmaceutical Industries, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.